On October 5, the world unites to recognize #WorldMeningitisDay. Meningitis can affect anyone, anytime, and it can progress rapidly. Without prompt treatment, it can be fatal within hours or lead to long-term health complications and suffering. However, with vaccination and timely action based on syndromic testing for symptoms, we can defeat meningitis. Join the fight to #DefeatMeningitis. #Seegene #Meningitis #AWorldFreeFromDiseases
About us
[INTRODUCING OUR COMPANY] The people of Seegene are on a purposeful mission to improve the world we live in. We aim to improve the quality of life for everyone globally by bringing molecular diagnostics to the masses. Molecular diagnostics is the most effective method to accurately diagnose ailments and is also the best way to diagnose them early which is when you can make the most difference in the recovery treatment. With industry-leading IP in molecular diagnostics reagent assays, we are dedicated to leveraging our unique technologies to increase our product portfolio, expand our market coverage, and lowering the total cost to serve our customers so that molecular diagnostics become a part of the fabric of everyone’s life and thus, improving the quality of life for everyone in the world. [OUR HISTORY AND OUR FUTURE] Since our founding in 2000, we have been steadfastly focused on molecular diagnostics. Currently, our product portfolio consists of over 250 molecular diagnostics reagent kits as well as a wide range of instruments and consumables that are sold globally. Testament to our expertise, when the pandemic started, Seegene was one of the first companies in the world to provide testing kits that were crucial in the fight against COVID. Today, we are a company with revenue of over $1 billion dollars and 65% gross margins. With 8 overseas entities, we generate a majority of our revenue outside of Korea. In keeping with our spirit of innovation and making a difference in the world, there are many exciting innovations being worked on at Seegene which will make it easier for the world to access the benefits of molecular diagnostics. We are transforming our business from a discrete reagent assay and instruments business to a platform business that will create new markets for molecular diagnostics and improve the quality of life for everyone. We hope that you will join us in our mission to make a meaningful difference in the world.
- Website
-
https://www.seegene.com/
External link for Seegene Inc.
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- 서울
- Type
- Public Company
- Founded
- 2000
- Specialties
- in-vitro diagnostics (IVD), companion diagnostics, molecular diagnostic (MoDx), nucleic acid testing (NAT), infectious disease detection, respiratory pathogen detection, and sexually transmitted disease (STD) detection
Locations
Employees at Seegene Inc.
Updates
-
Today’s the day! Don’t miss out on the exciting webinar we prepared in partnership with #Nature: "How Molecular Diagnostics Can Make an Impact on Public Health." Join Zoltan Fehervari, Senior Editor at Nature, and Ulrich Eigner, Head of Studies on Infection Diagnostics at Laboratory Limbach, as they share invaluable insights into infectious diseases and the impact of innovative diagnostics. ⌛ If you haven’t signed up yet, there’s still time—plus, registering gives you access to on-demand viewing after the live event! 🔗 Register now: https://bit.ly/4eA5TO9 ▶ Date & time: October 3, 2024 | 8:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST ▶ Presenters: Zoltan Fehervari & Ulrich Eigner #Seegene #SpringerNature #MolecularDiagnostics #MDxImpactGrants #NatureAwards
-
✨October is #HealthyLungMonth! Proper lung care is essential to overall health. Regular check-ups and early diagnosis of #pneumonia can help protect your lungs and keep you healthy. Let’s protect our lung health together! 🫁 #Seegene #LungHealth
-
💡 Discover how molecular diagnostics can make an impact on public health on October 3! In this webcast, Zoltan Fehervari, Senior Editor, Nature, will explore the outlook on infectious diseases now and on the horizon, and Ulrich Eigner, head of Studies on Infection Diagnostics at the Laboratory Limbach, will share his experience working with Seegene as a grantee of the Open Innovation Program, the predecessor to the MDx Impact Grants. You don't want to miss out on this! Register here: https://bit.ly/4eA5TO9 *Register now to also gain access to on-demand viewing after the live event. 🖥 Webcast details ▶ Subject: How Molecular Diagnostics Can Make an Impact on Public Health ▶ Date & time: October 3, 2024 | 8:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST ▶ Presenters: Zoltan Fehervari, Ulrich Eigner #Seegene #MolecularDiagnostics #OpenInnovationProgram #MDxImpactGrants
-
🧠 September 21 is World #Alzheimer’s Day, a global opportunity to raise awareness about dementia and Alzheimer’s disease. This year’s theme, "Know Dementia, Know Alzheimer’s," encourages us all to better understand these conditions, their symptoms, and how they affect those around us. Seegene stands with Alzheimer’s patients and their families, contributing to a future with better understanding and care for those affected. #Seegene #WorldAlzheimersDay #Dementia
-
🦠 If your pulmonary symptoms aren’t going away, it might be due to a #fungal infection! Persistent lung pains could be caused by a fungal infection, which can mimic the symptoms of common lung diseases, making them harder to diagnose and leading to delayed treatment & complications. Remember, early testing is key to ensuring the right treatment. #Seegene #FungalDiseaseAwareness #FungalWeek24 #ThinkFungus #EarlyTesting
-
🦠 It’s Fungal Disease Awareness Week! Did you know that fungal infections can often go undetected in the early stages, leading to delayed treatment? Early diagnosis is crucial to fighting these infections effectively. Syndromic testing detects multiple pathogens at once, providing fast and accurate results to ensure timely treatment. 🔍 What is syndromic testing? - Detects multiple pathogens at once - Provides rapid, reliable results - Supports early diagnosis and improves treatment outcomes #Seegene #FungalDiseaseAwareness #FungalWeek24 #SyndromicTesting #Seegene #ThinkFungus #EarlyDiagnosis
-
Today marks Seegene's 24th anniversary! 🎉 Over the past 24 years, your trust and support have enabled us to grow as a global leader in molecular diagnostics. We remain committed to pioneering innovative technologies that advance healthcare worldwide and create a brighter future. Thank you for your unwavering support, and we look forward to continuing this journey with you! #Seegene #24thAnniversary #AWorldFreefromDiseases
Seegene's 24th anniversary!
-
Join #Seegene at the 13th #EMMD, happening from October 9 to 11, in Noordwijk, Netherlands. Visit booth #9 to discuss how Seegene is advancing molecular technologies and transforming healthcare diagnostics. We look forward to connecting with you in Noordwijk and exploring the exciting possibilities in molecular diagnostics! #MolecularDiagnostics #EMMD2024 #EuropeanMeetingOnMolecularDiagnostics
-
🦠 COVID-19, RSV, or the Flu? 🤔 Can't tell them apart? 🌡️ Similar symptoms, different pathogens! It's almost impossible to differentiate based on symptoms alone. But don’t worry—syndromic testing offers a high level of diagnostic accuracy, ensuring you get the right treatment quickly. Protect yourself and others by getting tested. With a single syndromic test, you can accurately detect COVID-19, the flu, and RSV—and more. #Seegene #COVID19 #RSV #Flu #SyndromicTesting #SyndromicqPCR